< Back to previous page
Patent
METABOLIC MARKERS FOR DIAGNOSING OF CANCER
The present invention relates to a panel of metabolites in a body fluid sample that can be used for the diagnosis of breast, lung, colon and prostate cancer. More specifically, the invention relates to the NMR analysis of a urine or blood sample, whereby the simultaneous determination of the concentration of a panel of metabolites allows the diagnosis of breast, lung, colon or prostate cancer with a high sensitivity and specificity. In particular, the panel of metabolites comprises methyl histidine and proline.
Patent Publication Number: WO2011128256
Year filing: 2011
Year approval: 2012
Year publication: 2011
Status: Requested
URI: link to Espacenet
Technology domains: Measurement, Analysis of biological materials
Validated for IOF-key: Yes
Attributed to: Association University - Colleges Limburg